She had been exercising consistently for twenty years. Running, mostly. Some yoga. Occasionally a group fitness class. She was disciplined and proud of it.

At 47, her GP mentioned her bone density scan results. A slight decrease. Not alarming, but “worth watching.” At 49, the muscle loss she’d noticed — despite the same training schedule — was confirmed in a DEXA scan. And somewhere in the middle, she’d noticed her memory wasn’t quite what it had been.

Three separate problems. Nobody mentioned they had one solution.

The most consistent gap I see in the exercise conversations perimenopausal women are having is not motivation. It is information.

Women are doing the exercise they’ve always done — and wondering why their bodies are responding differently. The answer is not that their discipline has failed. It is that the biological requirements of their bodies have changed — specifically, that the exercise modality that was adequate at 35 is inadequate at 45, not because it is wrong, but because it is incomplete.

When I understood the three-system convergence — bone, muscle, brain — I couldn’t un-see it. One intervention class. Three of the highest-consequence long-term risks of perimenopause and menopause. All of them addressed with greater evidence than any pharmaceutical alternative available without prescription.

The conversation most women are not having with their clinicians — or their trainers — is this one.

Resistance training is not an aesthetic choice for perimenopausal women.

It is a medical intervention — for three of the highest-consequence long-term risks of this life stage. And the evidence supporting it is, across all three domains, unambiguous.

Bone: the most powerful osteogenic stimulus available without pharmacology

As estradiol falls, bone density loss accelerates significantly. Research is clear that this acceleration begins in perimenopause — not post-menopause — at rates of up to 2% per year in the years surrounding the final menstrual period. The standard DEXA screening guideline of age 65 is, for many high-risk women, arriving a decade after the accelerated loss has already occurred.

The most powerful osteogenic (bone-building) stimulus available without pharmacology is axial mechanical loading — the kind produced by squats, deadlifts, and overhead pressing movements. These exercises place compressive and tensile forces on bone, stimulating osteoblast activity (bone-building cells) through mechanical strain and the release of growth factors including IGF-1 and TGF-β.

Walking produces some osteogenic stimulus. Running produces more. Neither produces the magnitude of axial loading that heavy resistance training generates — particularly in the spine, hips, and shoulders, where osteoporotic fractures cause the most significant long-term disability.

This is not an opinion about preferred exercise modalities. It is a mechanistic statement: if bone protection is the goal, progressive loading resistance training is the most potent tool available.

Muscle: superior body composition outcomes — this is not preference, it is evidence

Estrogen receptors in muscle tissue directly support muscle protein synthesis. As estradiol declines, perimenopausal women lose approximately 0.5–1% of muscle mass per year beginning in the mid-40s — a process called sarcopenia. This loss compounds over the decade, producing changes in body composition, metabolic rate, and functional capacity that are incorrectly attributed to “normal aging.”

Muscle is the primary site of insulin-stimulated glucose disposal. Less muscle means less disposal capacity, higher chronic insulin, and greater visceral fat accumulation — the same metabolic cascade driven by the GLUT4 and insulin resistance mechanisms described in the estrogen-metabolism relationship.

Progressive overload resistance training produces measurably superior body composition outcomes compared to any form of aerobic training in perimenopausal women — not because aerobic training is without value, but because resistance training directly addresses muscle protein synthesis in a way that aerobic training does not. The two are complementary, not equivalent. Aerobic training for cardiovascular health; resistance training for muscle mass and body composition. Both belong in the same programme.

Protein requirements increase alongside this need for resistance training: 1.6–2.2g per kilogram of bodyweight is the evidence-based range for perimenopausal women who are training for muscle maintenance — significantly above standard dietary guidelines that were developed for younger, non-transitional populations.

Brain: the same exercise that protects your bones protects your neurons

Resistance training elevates BDNF — brain-derived neurotrophic factor, the protein responsible for neuroplasticity, hippocampal neurogenesis, and the maintenance of cognitive function under hormonal stress. It also elevates IGF-1, which crosses the blood-brain barrier and supports neuronal health directly.

Research on aerobic exercise and brain health is well-established. What is less widely known is that resistance training produces comparable — and in some studies, superior — BDNF elevations, particularly in the hippocampus. The same axial loading that stimulates osteoblasts is also producing the molecular environment that supports cognitive resilience.

This means that the exercise you are doing for your bones is simultaneously doing meaningful work for your brain. The convergence is not coincidental. It reflects the deep physiological integration of the hormonal systems in transition.

Recent research at the 2025 Menopause Society Annual Meeting confirmed that cardiovascular health during the menopause transition is a modifiable risk factor for cognitive decline — and that exercise interventions targeting cardiovascular and musculoskeletal health simultaneously are among the most protective combinations available.

What a programme actually looks like

This is not a prescription. But specificity matters, so: the evidence supports 2–3 sessions of progressive overload resistance training per week, targeting compound movements (squat pattern, hinge pattern, push, pull, carry), with progressive increases in load over time. “Progressive” is the operative word — the osteogenic and myogenic stimulus requires the load to be challenging enough to produce adaptation.

If you have never lifted weights, a qualified strength coach is worth the investment — not for aesthetics, but for safety and efficacy. If you have been lifting, the question is whether you are progressing the load. Maintenance-level resistance training produces maintenance outcomes. Progressive resistance training produces protective outcomes.

She went back to her GP after six months of progressive resistance training — two sessions a week, compound movements, incrementally increasing weights. Her follow-up DEXA showed bone density stability. Her muscle mass markers had improved. And somewhat unexpectedly, she told me her cognitive clarity had noticeably shifted in the months since she’d started.

“I thought I was lifting for my bones,” she said. “I didn’t realise I was also lifting for my brain.”

One intervention. Bone protection. Muscle maintenance. Cognitive resilience.

This is not a fitness trend. It is biology — and the evidence supporting resistance training for perimenopausal women across all three domains is among the strongest in the entire women’s health research landscape.

The most useful thing you can do this week: if your current exercise programme does not include progressive overload resistance training, identify one way to start. A trainer assessment, a first session at a gym, a conversation with your clinician about what is appropriate for your specific bone density and cardiovascular picture.

At EmpressHealth.ai, our Movement & Body Strength module assesses where you are in your exercise strategy relative to your hormonal picture — because a training plan that was built for your 35-year-old biology may need to be redesigned for the woman you are now.

Start lifting. Your bones, your muscles, and your brain are asking for exactly that.